| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/20/2008 | US20080070963 Compositions and methods for promoting neural regeneration |
| 03/20/2008 | US20080070962 Cannabinoid receptor antagonist; N-{[5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-1H-pyrazol-3-yl]methyl}-3-cyanobenzenesulfonamide; psychiatric disorder, substance dependence and withdrawal disorder, cognitive disorder, ADD, neurodegenerative diseases, pain, eating disorders, dyslipidemia, ulcer |
| 03/20/2008 | US20080070961 storage stability; precipitation |
| 03/20/2008 | US20080070960 Novel 3-Aryl-1,2-Benzisoxazole Derivatives and Use Thereof as Medicinal Products Against Cancer |
| 03/20/2008 | US20080070959 Guanylhydrazone compounds, compositions, methods of making and using |
| 03/20/2008 | US20080070958 Therapeutic Agent for Keratoconjunctival Disorder |
| 03/20/2008 | US20080070957 p-(2-alkoxy-2-acylethyl)biphenyl compounds; 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases,; lipid metabolism diseases; Peroxisome Proliferator-Activated Receptor modulator |
| 03/20/2008 | US20080070956 ATPase inhibitors; Substituted fluorene or benzenerings joined to an alkylene through a sulfone or sulfoxide linkage; without excessive toxicity, irritation, allergic response etc.; sleep dioredrs like excessive sleepiness; Parkinson's disease; Alzheimer's disease; ADD; ADHA; depression, fatigue |
| 03/20/2008 | US20080070954 inhibitors of histone deacetylase; antiproliferative; anticancer; 8-[3-(4-methylbenzenesulfonyl)-ureido])-octanoic acid hydroxyamide |
| 03/20/2008 | US20080070953 Inhibitors of interleukin-1 beta converting enzyme |
| 03/20/2008 | US20080070952 induced by L-dopa or dopamine agonist when treating Parkinson's Disease; administering a selective inhibitor of neuronal Nitric oxide synthase |
| 03/20/2008 | US20080070951 Viricides; HIV antivirals effective against problematic drug escape mutants; N-[(1S,1aR,7bR)-4,7-difluoro-1,1a,2,7b-tetrahydrocyclopropa[c]chromen-1-yl]-N'-[5-(4-(sulfonamido)phenoxy)-2-pyridinyl]urea |
| 03/20/2008 | US20080070950 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2- methylpropionic acid and its pharmaceutical compositions |
| 03/20/2008 | US20080070949 Polymorphs of rimonabant |
| 03/20/2008 | US20080070948 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain |
| 03/20/2008 | US20080070947 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 03/20/2008 | US20080070946 Hydroxymethylbenzothiazoles Amides |
| 03/20/2008 | US20080070945 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |
| 03/20/2008 | US20080070944 Novel methods using aminobenzoic acid compounds |
| 03/20/2008 | US20080070943 Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands |
| 03/20/2008 | US20080070942 Antiulcer, weakly inhibit gastric acid secretion, reduce the risk of stomach cancer, bioavailability, good pharmacokinetic properties; 2-(pyridylmethylsulfinyl)benzimidazoles such as 2-([4-3-methoxy-propoxy)-3-methylpyridine-2-yl]-methyl-sulfinyl)-1H-5-difluoromethoxybenzimidazole sodium salt |
| 03/20/2008 | US20080070941 Derivatives of n-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics |
| 03/20/2008 | US20080070940 Side effect reduction of emesis; phosphodiesterase 4 (PDE4) inhibitor; 2-(3'-[3-[(cyclopropylamino)carbonyl)-4-oxo-1,8-naphthyridin-1(4H)-yl]-3-fluoro-1,1'-biphenyl-4-yl)cyclopropanecarboxylic acid, sodium salt; crystalline forms; allergies, autoimmune diseases, cancer, neurodegenerative disorders |
| 03/20/2008 | US20080070939 Use of dextromethorphan hydrobromide monohydrate, dextrorphan tartrate, or 3-methoxymorphinan hydrochloride |
| 03/20/2008 | US20080070938 HMG-CoA reductase inhibitor and pyridoxine, pyridoxal, or pyridoxamine; combination therapy; pravastatin, simvastatin, atorvastatin |
| 03/20/2008 | US20080070937 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 03/20/2008 | US20080070936 Compounds specific to adenosine A1 receptors and uses thereof |
| 03/20/2008 | US20080070935 Isoquinoline, Quinazoline and Phthalazine Derivatives |
| 03/20/2008 | US20080070934 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 03/20/2008 | US20080070933 Purine, Pyrimidine, and Azaindole Derivatives |
| 03/20/2008 | US20080070932 unexpectedly potent antagonists of A2a adenosine receptor; Parkinson's; neurodegenerative diseases; 2-furan-2-yl-N5-[1-(5-methyl-isoxazol-3-ylmethyl)-pyrrolidin-2-ylmethyl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-diamine |
| 03/20/2008 | US20080070931 5-phenyl-nicotinamide derivatives |
| 03/20/2008 | US20080070930 2-(4-oxo-4,5,6,7-tetrahydroindol-1-yl) or 2-(4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl) pyrimidines or pyrazines; cancer, inflammation, arthritis, angiogenesis, fungal, viral and Plasmodium infections; Heat Shock Protein 90 inhibitors |
| 03/20/2008 | US20080070929 Thiazoline and oxazoline derivatives and their methods of use |
| 03/20/2008 | US20080070928 Novel 2-Heteroaryl-Substituted Benzimidazole Derivative |
| 03/20/2008 | US20080070927 Substituted Heterocyclic Compounds |
| 03/20/2008 | US20080070926 Therapeutic Combinations of Manidi Pine and a Statin |
| 03/20/2008 | US20080070925 Serotonergic agents for treating sexual dysfunction |
| 03/20/2008 | US20080070924 Neurokinin (NK1, substance P) antagonists; used for side effect reduction of emesis, respiratory depression, and opioid tolerance of opioid analgesics; 4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-piperazine acetamide for example |
| 03/20/2008 | US20080070923 3-isopropyl-2-oxo-2,3-dihydrobenzoimidazole-1-carboxylic acid [8-((S)-2-hydroxy-3-methylamino-propyl)-8-azabicyclo[3.2.1]oct-3-yl]-amide; 5-HT4 receptor agonist; bioavailability upon oral administration; treating a disorder of reduced motility of the gastrointestinal tract |
| 03/20/2008 | US20080070922 DDPIV inhibitor: selected from (S)-1-{2-[5-cyanopyridin-2yl)amino]ethyl-aminoacetyl)-2-cyano-pyrrolidine, vildagliptin, Sitagliptin, saxagliptin; PDGF receptor tyrosine kinase inhibitor: selected from imatinib, imatinib methanesulfonate; impaired glucose metabolism; impaired glucose tolerance |
| 03/20/2008 | US20080070921 Melanocortin receptor modulators; sexual disorders, obesity, cachexia, eating disorders; for example 1,4-bis(2-amino-3-p-tolyl-propionyl)-2-isobutyl-5-(4-(2-aminoethylamino)butyl)piperazine |
| 03/20/2008 | US20080070920 Novel HIV reverse transcriptase inhibitors |
| 03/20/2008 | US20080070919 Serotonin reuptake inhibitors and antagonists of the serotonin 1A receptor; compounds are based on 7,9-diazabicyclo(4.2.2)dec-3-ene ring |
| 03/20/2008 | US20080070918 Heat Shock Protein-90 (HSP-90) inhibitors; cancer, inflammation, arthritis, angiogenesis, antimalaria, fungal and viral infections; 2-(4-Hydroxy-cyclohexylamino)-4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-4H-cinnolin-1-yl)-benzamide for example; synthesis from corresponding benzonitriles |
| 03/20/2008 | US20080070917 Methods for administering levosimendan |
| 03/20/2008 | US20080070916 Treating disorders such as proliferative diseases, and cancer; compounds can act as probes of biological function; libraries; for example, 2-ethoxy-3-(2-hydroxyethoxyethoxyethyl)-4-(1-acetylindol-3-yl)-6-(morpholinocarbonyl)-2H-3,4-dihydropyran |
| 03/20/2008 | US20080070915 Poly(ADP-ribose)polymerase (PARP); ischemia, reperfusion injuries, neurological disorders, neuroprotectants, sensitizer for chemotherapy or radiotherapy, anticancer |
| 03/20/2008 | US20080070914 Inhibitors of cell cycle kinases such as cyclin dependent kinase CDK4 and/or the Aurora kinases; use in combination with an anticancer agent |
| 03/20/2008 | US20080070913 Thieno [ 3,2-b] pyridine-6-carbonitriles and thieno [2,3-b] pyridine-5-carbonitriles as protein kinase inhibitors |
| 03/20/2008 | US20080070912 Phosphodiesterase inhibitors; neuropathic pain, inflammation, opioid dependence or withdrawal; 2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one for example |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070910 aromatic or heterocyclic/heterobicyclic carbamate compounds as protease inhibitors , useful for inhibiting the development of drug resistance of HIV in HIV infected animals; improved pharmacokinetics; protease inhibitors |
| 03/20/2008 | US20080070909 Of amine salts of 1-(3-(2-(3-methanesulfonamino-4-hydroxyphenyl)-2-hydroxyethylamino)-3,3-dimethylpropyl)-1,2-dihydro-4H-3,1-benzoxazin-2-one betamimetics; physicochemical properties for use in inhalable form; treating respiratory system disorders |
| 03/20/2008 | US20080070908 Compositions including antibiotics and methods for using same |
| 03/20/2008 | US20080070907 Substituted chiral fused [1,2] imidazo [4,5-C] ring compounds and methods |
| 03/20/2008 | US20080070906 Quinolinone derivatives |
| 03/20/2008 | US20080070905 An enzyme in the tryptophan degradation pathway, used to treat neurodegenerative disorders, certain cancers, drug addiction; 2-sulfonamido-substituted oxazole, imidazole or thiazole compounds such as 3,4-dimethoxy-N-[4-(3-nitrophenyl)-5-dimethylaminomethyl-1,3-thiazole-2-yl]benzenesulfonamide |
| 03/20/2008 | US20080070904 intranasal delivery of lorazepam or diazepam in binary solvents, soluble in 1st solvent ( diethylene glycol, monoethyl ether, tetrahydrofurfuryl alcohol polyethylene glycol), capable of penetrating nasal mucuosa, lesssoluble in 2nd solvent ( propylene glycol, glycerol triacetate); greater bioavailabiltiy |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | US20080070902 Cinnamide Compound |
| 03/20/2008 | US20080070901 Cholineterase inhibitors for treating inflammation |
| 03/20/2008 | US20080070900 Administering galantamine or galantamine hydrobromide antidotes to a human at a risk of exposure to parathion or malathion toxicity, subsequently administering atropine as an antimuscarinic agen. |
| 03/20/2008 | US20080070899 (Calcitonin gene related peptide); headache, migraine and cluster headache; spiropiperidine-substituted azepan-2-ones such as 1-(2,2,2-trifluoroethyl)-3-(1-oxo-2,8-diazaspiro[4.5]decan-8-yl-aminocarbonylamino)6-(2,3-difluorophenyl)azepan-2-one |
| 03/20/2008 | US20080070898 Sodium channel inhibitor of low side effect; analgesics; neuropathic pain; 4-(2-{4-[(E)-2-(2-methylphenyl)vinyl]piperidin-1-yl}-2-oxoethyl)morpholine for example |
| 03/20/2008 | US20080070897 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component (ethanol) , a surfactant such as polyglycerol, polyoxyethylene castor oil |
| 03/20/2008 | US20080070896 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 03/20/2008 | US20080070895 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase |
| 03/20/2008 | US20080070894 Anticancer agents; PLK1 inhibitors; PLK=polo-like kinase; imidazo(1,2-a)pyridines such as 5-bromo-4-[8-(difluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-1-phenylethyl]-2-pyrimidinamine |
| 03/20/2008 | US20080070893 Cancer, neurological disorders, autoimmune disorders; inhibitors of CK2, a serine/threonine kinase; based upon macrocyclic pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine compounds |
| 03/20/2008 | US20080070892 2,7-diazaspiro[3.5]nonane; TRPV1 antagonists; Transient receptor potential V1 (TRPV1); T-type calcium channel blockers; Niemann-Pick C1-like (NPC1L1) antagonists; combination therapy with other antidiabetics, analgesics |
| 03/20/2008 | US20080070891 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 03/20/2008 | US20080070890 Spirocyclic Azetidinone Compounds and Methods of Use Thereof |
| 03/20/2008 | US20080070889 Spirocyclic azetidin(one); e.g. 2,7-diazaspiro[3.5]nonan-1-one; T-type calcium channel blockers; Niemann-Pick C1-like (NPC1L1) antagonists |
| 03/20/2008 | US20080070888 Spirocyclic azetidin(one); 2-(3-chloro-4-fluorophenyl)-7-[5-fluoro-6-(trifluoromethyl)-1H-benzimidazol-2-yl]-3-(2-pyridinyl)-2,7-diazaspiro[3.5]nonan-1-one; T-type calcium channel blockers |
| 03/20/2008 | US20080070887 Diaryl Ether Derivatives and Uses Thereof |
| 03/20/2008 | US20080070886 Anti-cancer combinations |
| 03/20/2008 | US20080070885 disorders related to beta-amyloid such as Alzheimer's disease, Down's Syndrome, memory and cognitive impairment, dementia, amyloidosis; (2R,4S) N-Butyl-4-hydroxy-2-methyl-4-((10S,13S)-10-methyl-8,11-dioxo-2-oxa-9,12-diaza-bicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-13-yl)-butyramide for example |
| 03/20/2008 | US20080070884 Antibiotics; novel class of cell wall biosynthesis inhibitors without cross-resistances to known classes of antibiotics; active analogs of lysobactin with a higher ring stability |
| 03/20/2008 | US20080070883 N-(2,2,2-trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzene sulfonamide; hydroxycholesterols, epoxycholesterol, paxilline, desmosterol, or stigmasterol, N,N-dimethyl-3 beta -hydroxycholenamide and other oxysterols or nonoxysterols used as liver-x-receptor modulators |
| 03/20/2008 | US20080070882 sodium 17 alpha/17-beta-estradiol sulfate, sodium 17 alpha/17 beta-dihydroequilin sulfate, sodium estrone sulfate, sodium equilin sulfate, sodium 17 alpha/ 17-beta -dihydroequilenin sulfate, sodium equilenine sulfate, sodum estrone sulfate, butyleated hydroxyanisole stabilizer; menopausal conditions |
| 03/20/2008 | US20080070881 Prostate Cancer Treatment |
| 03/20/2008 | US20080070880 Specific glucocorticosteroid compound having anti-inflammatory activity |
| 03/20/2008 | US20080070879 7-keto dhea for psychiatric use |
| 03/20/2008 | US20080070878 Foaming composition for washing and treating hair and/or scalp based on an active principle |
| 03/20/2008 | US20080070877 Combining parts of Epilobium Parviflorum plant with sugar cane alcohol , stirring and resting the mixture, filtering to get plant extract for treating Benign Prostatic Hyperplasia; side effect reduction; 5-alpha-reductase inhibitor |
| 03/20/2008 | US20080070876 Gaba-Steroid Antagonists And Their Use For The Treatment Of Cns Disorders |
| 03/20/2008 | US20080070875 Acne treatment compositions and methods of use |
| 03/20/2008 | US20080070874 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 03/20/2008 | US20080070873 Methods of increasing oral bioavailability of tetracyclines |
| 03/20/2008 | US20080070872 Method for the treatment of acne |
| 03/20/2008 | US20080070871 N-Phenylphosphoric Acid Triamides, Method for the Production Thereof and Their Use as Agents for Regulating or Inhibiting Enzymatic Urea Hydrolysis |
| 03/20/2008 | US20080070870 Using 3-omega fatty acid rich marine phospholipid, made by reacting soybean or egg lecithin with docosahexanoic acid and eicosapentaenoic acid in presence of lipase enzyme, for memory loss, forgetfulness, short-term memory loss, aphasia, disorientation, disinhibition, and behavioral changes |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080070868 Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase |
| 03/20/2008 | US20080070867 2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases |
| 03/20/2008 | US20080070866 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example |
| 03/20/2008 | US20080070865 Inhibiting a taste modulating protein; used in pharmaceutical, food, and other products to inhibit certain taste functions and perceptions; side effects reduction |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | US20080070862 Methods using glycosaminoglycans for the treatment of nephropathy |